Global Pharyngitis Treatment Industry Trends: Where the Market Is Headed by 2029

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Was The Pharyngitis Treatment Market Worth In 2025, And What Is Its Anticipated Value By 2029?

The pharyngitis treatment market has experienced steady growth in its size during recent years. Projections indicate a rise from $2.27 billion in 2024 to $2.37 billion in 2025, reflecting a compound annual growth rate (CAGR) of 4.2%. Historically, this expansion has been driven by factors such as the significant prevalence and increasing occurrence of influenza, the rising incidence of pharyngitis, heightened public understanding of pharyngitis, better availability of healthcare services, and an increase in disposable incomes.

The pharyngitis treatment market is anticipated to experience robust expansion over the coming years. It is projected to reach $3 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 6.1%. This growth during the forecast period is attributable to factors such as the increasing adoption of rapid point-of-care tests, the growing demand for personalized medicine, the widespread prevalence of antibiotic resistance, and the increasing significance of hand hygiene. Key trends anticipated in the forecast period encompass advancements in the research and development of pharyngitis therapies, the proliferation of digital health technologies, and enhanced telehealth integration.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=12937&type=smp

Which Industry Drivers Are Expected To Accelerate The Pharyngitis Treatment Market From 2025 To 2029?

The increased incidence of strep throat is expected to propel the growth of the pharyngitis treatment market going forward. Strep throat is a contagious bacterial infection primarily affecting the throat and tonsils. Prompt and effective antibiotic treatment for strep throat helps to alleviate symptoms, prevent complications, and reduce the risk of spreading the infection to others. For instance, in June 2022, data from the Centers for Disease Control and Prevention, a US-based government agency, showed that approximately 14,000 to 25,000 cases of invasive group A strep disease occur every year in the United States. Additionally, strep diseases account for 5.2 million outpatient visits and 2.8 million antibiotic prescriptions annually. Therefore, the rising transmission of strep throat drives the pharyngitis treatment market.

What Are The Key Segments In The Pharyngitis Treatment Market?

The pharyngitis treatmentmarket covered in this report is segmented –

1) By Drug Class: Beta Lactams; Macrolides; Cephalosporins; Fluoroquinolones; Tetracycline; Other Drug Classes

2) By Source of Infection: Viral; Bacterial

3) By Modes Of Delivery: Oral; Intravenous; Intramuscular; Other Modes Of Delivery

4) By End-Users: Hospitals; Homecare; Specialty Centers; Other End-Users

Subsegments:

1) By Beta Lactams: Penicillins; Amoxicillin; Ampicillin

2) By Macrolides: Erythromycin; Azithromycin; Clarithromycin

3) By Cephalosporins: Cefuroxime; Ceftriaxone; Cefdinir

4) By Fluoroquinolones: Ciprofloxacin; Levofloxacin; Moxifloxacin

5) By Tetracycline: Doxycycline; Minocycline; Tetracycline

6) By Other Drug Classes: Clindamycin; Sulfonamides; Carbapenems

Which Competitive Trends Are Defining The Pharyngitis Treatment Market Structure?

Key companies active in the pharyngitis treatment market are prioritizing the creation of advanced products, such as oral monotherapy, to boost patient adherence and deliver efficient, convenient therapeutic choices. Oral monotherapy denotes the application of a singular drug or medicine taken orally to address a specific ailment or condition. This approach involves administering only one therapeutic agent, in contrast to combining multiple treatments, to achieve the desired effect. For example, in December 2023, Novartis AG, a pharmaceutical company based in Switzerland, obtained FDA approval for Fabhalta (iptacopan), positioning it as the inaugural oral monotherapy for adults diagnosed with paroxysmal nocturnal hemoglobinuria (PNH). This landmark, achieved on [date], signifies a considerable leap forward by providing a new treatment alternative that elevates hemoglobin levels, thus eradicating the necessity for blood transfusions.

Who Are The Core Companies Influencing The Pharyngitis Treatment Market Landscape?

Major companies operating in the pharyngitis treatment market are Pfizer Inc., GlaxoSmithKline PLC, Genentech Inc., Pliva Hrvatska D.o.o., Viatris Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Medtronic PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Bausch Health Companies Inc., Sun Pharmaceutical Industries Ltd., Dr. Reddy’s Laboratories Ltd., Cipla Limited, Hikma Pharmaceuticals PLC, Lupin Limited, Pliva Hrvatska D.o.o., LivaNova PLC, Genentech Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/pharyngitis-treatment-global-market-report

How Do Regional Market Performances Compare Within The Pharyngitis Treatment Industry?

North America was the largest region in the pharyngitis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in pharyngitis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Pharyngitis Treatment Market Report:

https://www.thebusinessresearchcompany.com/customise?id=12937&type=smp

Browse Through More Reports Similar to the Global Pharyngitis Treatment Market 2025, By The Business Research Company

Inflammatory Bowel Disease Treatment Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/inflammatory-bowel-disease-treatment-global-market-report

Non Steroidal Anti Inflammatory Drugs Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/non-steroidal-anti-inflammatory-drugs-global-market-report

Cystic Fibrosis Cf Therapeutics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cystic-fibrosis-cf-therapeutics-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795